Jill Long

745 total citations
15 papers, 406 citations indexed

About

Jill Long is a scholar working on Public Health, Environmental and Occupational Health, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jill Long has authored 15 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Jill Long's work include Hormonal and reproductive studies (7 papers), Reproductive Health and Contraception (6 papers) and Sexual Differentiation and Disorders (4 papers). Jill Long is often cited by papers focused on Hormonal and reproductive studies (7 papers), Reproductive Health and Contraception (6 papers) and Sexual Differentiation and Disorders (4 papers). Jill Long collaborates with scholars based in United States, United Kingdom and Ireland. Jill Long's co-authors include Diana Blithe, Min S. Lee, Kenneth Lawrence, Arlene C. Seña, Michael R. Wierzbicki, Byron E. Batteiger, Jeanne Marrazzo, John P. Mueller, Stephanie N. Taylor and Edward W. Hook and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Jill Long

15 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jill Long United States	9	179	109	93	77	61	15	406
T. M. T. Mulders Netherlands	13	587 3.3×	85 0.8×	115 1.2×	170 2.2×	9 0.1×	22	928
Edwin Thorpe United States	8	51 0.3×	42 0.4×	11 0.1×	23 0.3×	18 0.3×	10	343
J. Garza‐Flores Mexico	16	313 1.7×	14 0.1×	59 0.6×	146 1.9×	11 0.2×	47	611
Xijing Han United States	7	75 0.4×	15 0.1×	97 1.0×	17 0.2×	61 1.0×	12	271
Maria Malm Poland	13	68 0.4×	7 0.1×	92 1.0×	33 0.4×	25 0.4×	33	417
Bamgboye M Afolabi Nigeria	10	239 1.3×	6 0.1×	30 0.3×	10 0.1×	22 0.4×	45	403
Usha Joshi India	11	64 0.4×	7 0.1×	56 0.6×	58 0.8×	13 0.2×	41	358
Gabriela Moreno United Kingdom	10	20 0.1×	107 1.0×	59 0.6×	110 1.4×	21 0.3×	34	316
Abdelmonem S. Hassan Qatar	11	134 0.7×	16 0.1×	35 0.4×	25 0.3×	64 1.0×	25	354

Countries citing papers authored by Jill Long

Since Specialization

Citations

This map shows the geographic impact of Jill Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Long more than expected).

Fields of papers citing papers by Jill Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Long. The network helps show where Jill Long may publish in the future.

Co-authorship network of co-authors of Jill Long

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Long. A scholar is included among the top collaborators of Jill Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Long. Jill Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nguyen, Brian T., Arthi Thirumalai, John K. Amory, et al.. (2021). Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial. Contraception. 104(5). 531–537. 8 indexed citations

Thirumalai, Arthi, Ronald S. Swerdloff, Peter Y. Liu, et al.. (2021). Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β‐MNTDC in healthy men. Andrology. 9(5). 1526–1539. 6 indexed citations

Long, Jill, Min S. Lee, & Diana Blithe. (2021). Update on Novel Hormonal and Nonhormonal Male Contraceptive Development. The Journal of Clinical Endocrinology & Metabolism. 106(6). e2381–e2392. 41 indexed citations

Sinha, Subarna, Merrill Knapp, Peter B. Madrid, et al.. (2021). Contraceptive and Infertility Target DataBase: a contraceptive drug development tool for targeting and analysis of human reproductive specific tissues†. Biology of Reproduction. 105(6). 1366–1374. 4 indexed citations

Chen, Melissa J., Mitchell D. Creinin, David K. Turok, et al.. (2020). Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate. Contraception. 102(3). 168–173. 7 indexed citations

Long, Jill, et al.. (2020). Menstrual Cup Use and Intrauterine Device Expulsion in a Copper Intrauterine Device Contraceptive Efficacy Trial [OP01-1B]. Obstetrics and Gynecology. 135(1). 1S–1S. 4 indexed citations

Thirumalai, Arthi, John K. Amory, Andrew N. Hoofnagle, et al.. (2020). Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 Days. The Journal of Clinical Endocrinology & Metabolism. 106(1). e171–e181. 8 indexed citations

Thirumalai, Arthi, Ronald S. Swerdloff, Bradley D. Anawalt, et al.. (2020). Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men. The Journal of Clinical Endocrinology & Metabolism. 105(3). e835–e847. 30 indexed citations

Long, Jill, Min S. Lee, & Diana Blithe. (2019). Male Contraceptive Development: Update on Novel Hormonal and Nonhormonal Methods. Clinical Chemistry. 65(1). 153–160. 33 indexed citations

10.

Wu, Sherry Y., Arthi Thirumalai, Ronald S. Swerdloff, et al.. (2018). Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel. Andrology. 7(2). 235–243. 14 indexed citations

11.

Taylor, Stephanie N., Jeanne Marrazzo, Byron E. Batteiger, et al.. (2018). Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea. New England Journal of Medicine. 379(19). 1835–1845. 149 indexed citations

12.

Long, Jill, Michael R. Wierzbicki, & Edward W. Hook. (2017). Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment. Sexually Transmitted Diseases. 44(6). 362–364. 1 indexed citations

13.

Power, Dermot, et al.. (2016). Frailty and its association with rehabilitation outcomes in a post-acute older setting. International Journal of Therapy and Rehabilitation. 23(1). 33–40. 11 indexed citations

14.

Sheffield, Jeanne S., David Siegel, Mark Mirochnick, et al.. (2014). Designing Drug Trials: Considerations for Pregnant Women. Clinical Infectious Diseases. 59(suppl_7). S437–S444. 78 indexed citations

15.

Stephenson, Diane, Andres D. Ramirez, Jill Long, et al.. (2006). Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection. Journal of Neuroscience Methods. 159(2). 291–299. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact